As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the life sciences tools & services industry, including 10x Genomics (NASDAQ:TXG) and its peers. The ...

The Global Multi-omics Market comprising primarily Genomics, Transcriptomics, Proteomics, & Metabonomics is set to witness a ...

Ratings for 10x Genomics TXG were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.. The table below offers a condensed view of their recent ...

10x Genomics (TXG) has faced significant revenue declines and operational challenges. Read my review of TXG's preliminary Q3 results here.

10x Genomics, Inc. (NASDAQ: TXG) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. It has announced a ...

PLEASANTON, Calif., March 3, 2025 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences ...

10x Genomics has settled patent infringement lawsuits with a pair of rivals, Bruker and Vizgen, through settlements that could reshape competition within the emerging single-cell and spatial ...

PLEASANTON, Calif., Sept. 3, 2024 /PRNewswire/ --10x Genomics, Inc. (Nasdaq: TXG ), a leader in single cell and spatial biology, today annou Tuesday, 02 January 2024 12:17 GMT عربي ...

The new offering, which includes an automation-friendly library preparation kit from 10x Genomics and an optimized method from Beckman Coulter Life Sciences, is designed to enable greater ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the life sciences tools & services industry, including 10x Genomics (NASDAQ:TXG) and its peers.

PLEASANTON, Calif., March 3, 2025 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences ...